Antirheumatic Drugs and the Risk of Tuberculosis
Top Cited Papers
Open Access
- 15 September 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (6) , 717-722
- https://doi.org/10.1086/506935
Abstract
Background. We aimed to quantify the rate of Mycobacterium tuberculosis disease (TB) among a cohort of patients with rheumatoid arthritis (RA) and toKeywords
This publication has 18 references indexed in Scilit:
- Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenArthritis & Rheumatism, 2005
- Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor InhibitorClinical Infectious Diseases, 2004
- Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatmentsRheumatic Disease Clinics of North America, 2004
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Cigarette smoking, TB, and TNF inhibitorsAnnals of the Rheumatic Diseases, 2003
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITISInfectious Disease Clinics of North America, 2001
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989